The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.51
Bid: 3.02
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.98 (32.45%)
Open: 3.51
High: 0.00
Low: 0.00
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Sciences Outlook Positive; Sales Remain Stable In Five Months

Fri, 26th Jun 2020 14:52

(Alliance News) - Proteome Sciences PLC on Friday reported stable sales in the first five months of 2020 and said it expects "this positive trend" to continue for the reminder of the year.

Ahead of its annual general meeting, the science research company reported continued progress throughout the business after delivering profit after tax in 2019.

Proteome Sciences said it has experienced good growth in services revenue and sales of both TMT and TMTpro have remained stable over the first five months of 2020.

"Despite the challenges of the Covid-19 pandemic, our dedicated staff have ensured we remained fully operational and have delivered 11 projects carried over from 2019 for which we already had samples," said Chair Christopher Pearce.

A further 10 projects are ongoing and new orders are also being generated, Proteome Sciences noted.

"We expect these positive trends to continue through the rest of the year," added Pearce.

AIM-listed Proteome Sciences shares were trading 6.5% lower in London on Friday afternoon at 3.50 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Aug 2022 15:33

Proteome reaches milestone in launch of proteomics service

(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.

Read more
16 May 2022 16:20

TRADING UPDATES: Proteome set for profit rise; Kromek expects loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
16 May 2022 13:35

Proteome Sciences maintains strong order book

(Sharecast News) - Proteome Sciences said in an update on Monday that it had maintained a strong order book after recording a small profit in 2021.

Read more
12 May 2022 11:14

IN BRIEF: Proteome Sciences secures contract with US academic group

Proteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism.

Read more
12 May 2022 10:47

AIM WINNERS & LOSERS: Arc Minerals "turning point"; Titon posts loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
22 Apr 2022 12:01

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

Read more
31 Mar 2022 13:04

TRADING UPDATES: Impellam and Maintel in profit; Curtis Banks prospers

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Mar 2022 19:23

IN BRIEF: Proteome Sciences amends GBP1 million loan with Vulpes

Proteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility.

Read more
29 Mar 2022 15:01

UK earnings, trading statements calendar - next 7 days

Wednesday 30 March 
Anglo Pacific Group PLCFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Bowleven PLCHalf Year Results
Canadian Overseas Petroleum LtdFull Year Results
Ebiquity PLCFull Year Results
Equals Group PLCFull Year Results
Gulf Keystone Petroleum LtdFull Year Results
Inspired PLCFull Year Results
Keywords Studios PLCFull Year Results
Michelmersh Brick Holdings PLCFull Year Results
Shepherd Neame LtdHalf Year Results
Team17 Group PLCFull Year Results
Thursday 31 March 
Eleco PLCFull Year Results
BBGI Global Infrastrcture SAFull Year Results
Chesnara PLCFull Year Results
Gattaca PLCHalf Year Results
Hostelworld Group PLCFull Year Results
James Halstead PLCHalf Year Results
Mears Group PLCFull Year Results
Record PLCFull Year Results
RTW Venture Fund LtdFull Year Results
S4 Capital PLCFull Year Results
Sportech PLCFull Year Results
Proteome Sciences PLCFull Year Results
Provident Financial PLCFull Year Results
Friday 1 April 
HydrogenOne Capital Growth PLCFull Year Results
Renew Holdings PLCTrading Statement
Medica Group PLCFull Year Results
Monday 4 April 
CentralNic Group PLCFull Year Results
Elixirr International PLCFull Year Results
Xpediator PLCFull Year Results
Tuesday 5 April 
DP Eurasia NVFull Year Results
Homeserve PLCTrading Statement
Moonpig Group PLCTrading Statement
Next Fifteen Communications Group PLCFull Year Results
Quixant PLCFull Year Results
SourceBio International PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more
20 Dec 2021 11:41

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

Read more
20 Dec 2021 10:45

Proteome Sciences shares climb on GBP1 million contract win

Proteome Sciences shares climb on GBP1 million contract win

Read more
20 Dec 2021 10:08

Proteome Sciences secures $1m contract with pharmaceutical major

(Sharecast News) - Proteomics and biomarker research firm Proteome Sciences has secured a contract valued at more than £1.0m from an unnamed major pharmaceutical company.

Read more
29 Jul 2021 18:17

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

Read more
18 Jun 2021 19:20

IN BRIEF: Proteome Sciences amends loan facility with Vulpes

IN BRIEF: Proteome Sciences amends loan facility with Vulpes

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.